Chen Wu

2.2k total citations · 1 hit paper
78 papers, 1.5k citations indexed

About

Chen Wu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Chen Wu has authored 78 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 23 papers in Cancer Research and 19 papers in Oncology. Recurrent topics in Chen Wu's work include Cancer-related molecular mechanisms research (14 papers), MicroRNA in disease regulation (11 papers) and Ferroptosis and cancer prognosis (7 papers). Chen Wu is often cited by papers focused on Cancer-related molecular mechanisms research (14 papers), MicroRNA in disease regulation (11 papers) and Ferroptosis and cancer prognosis (7 papers). Chen Wu collaborates with scholars based in China, United States and South Korea. Chen Wu's co-authors include Jingting Jiang, Wenwei Hu, Xiao Zheng, Qi Wang, Bin Xu, You Zhou, Changping Wu, Qi Zhou, Lujun Chen and Zhuojun Zheng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Journal of Agricultural and Food Chemistry.

In The Last Decade

Chen Wu

73 papers receiving 1.5k citations

Hit Papers

A novel protein encoded by a circular RNA circPPP1R12A pr... 2019 2026 2021 2023 2019 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling
    2019 425 citations Xiao Zheng, Lujun Chen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chen Wu China 19 1.0k 641 160 144 141 78 1.5k
Xiaoli Zhu China 22 948 0.9× 689 1.1× 208 1.3× 109 0.8× 140 1.0× 57 1.6k
Dandan Fan China 20 821 0.8× 517 0.8× 170 1.1× 127 0.9× 247 1.8× 63 1.4k
Wei Mu China 22 1.0k 1.0× 501 0.8× 175 1.1× 115 0.8× 188 1.3× 47 1.6k
Johannes Winkler Austria 24 1.5k 1.5× 453 0.7× 142 0.9× 81 0.6× 152 1.1× 78 2.3k
Chenguang Zhang China 18 741 0.7× 381 0.6× 140 0.9× 111 0.8× 122 0.9× 60 1.5k
Xingwen Wang China 22 933 0.9× 558 0.9× 185 1.2× 89 0.6× 374 2.7× 53 1.7k
Frances L. Byrne Australia 22 1.2k 1.2× 603 0.9× 166 1.0× 57 0.4× 117 0.8× 53 1.9k
Antonia Marazioti Greece 15 834 0.8× 324 0.5× 104 0.7× 118 0.8× 258 1.8× 40 1.9k
Lin Zhong China 22 578 0.6× 255 0.4× 181 1.1× 80 0.6× 162 1.1× 72 1.5k
Shuxia Zhang China 21 729 0.7× 371 0.6× 136 0.8× 116 0.8× 77 0.5× 76 1.3k

Countries citing papers authored by Chen Wu

Since Specialization
Citations

This map shows the geographic impact of Chen Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Wu more than expected).

Fields of papers citing papers by Chen Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chen Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Wu. The network helps show where Chen Wu may publish in the future.

Co-authorship network of co-authors of Chen Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Chen Wu. A scholar is included among the top collaborators of Chen Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chen Wu. Chen Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Shuang, Ruonan Shao, Qi Wang, et al.. (2025). Lactylation-driven MVP upregulation boosts immunotherapy resistance by inhibiting PD-L1 degradation in hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. 13(9). e012230–e012230. 1 indexed citations
2.
Gong, Xue, et al.. (2025). Evidence-Based Nursing Competence in Pediatrics: A Cross-Sectional Examination of Current Practices and Influencing Factors. The Journal of Continuing Education in Nursing. 56(6). 237–244.
3.
Wang, Zi, et al.. (2025). Empagliflozin attenuates DOX-induced cardiotoxicity by inhibiting RIPK1-mediated endoplasmic reticulum stress and autophagy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(6). 167898–167898. 4 indexed citations
4.
Wu, Ping, Xinjie Chen, Liping Chen, et al.. (2025). Aberrant Notch-signaling promotes tumor angiogenesis in esophageal squamous-cell carcinoma. Signal Transduction and Targeted Therapy. 10(1). 233–233. 2 indexed citations
5.
Wu, Chen, et al.. (2024). Systemic immune inflammation index and gastric cancer prognosis: A systematic review and meta‑analysis. Experimental and Therapeutic Medicine. 27(3). 122–122. 9 indexed citations
6.
Qin, Jian, Chen Wu, Jia Li, et al.. (2024). Pharmacodynamic components and mechanisms of ginger (Zingiber officinale) in the prevention and treatment of colorectal cancer. Journal of Ethnopharmacology. 324. 117733–117733. 9 indexed citations
7.
Ning, Jinzhuo, et al.. (2024). Comprehensive analysis indicated that NDE1 is a potential biomarker for pan‐cancer and promotes bladder cancer progression. Cancer Medicine. 13(5). e6931–e6931. 3 indexed citations
8.
Wu, Chen, et al.. (2024). Exosomes on the development and progression of renal fibrosis. Cell Proliferation. 57(11). e13677–e13677. 5 indexed citations
9.
Wu, Chen, et al.. (2023). The role of LncRNA‐regulated autophagy in AKI. BioFactors. 49(5). 1010–1021. 6 indexed citations
10.
Zhang, Yi, Fengqi Zhang, Zhixing He, et al.. (2023). Efficacy and safety of tofacitinib combined with methotrexate in the treatment of rheumatoid arthritis: A systematic review and meta-analysis. Heliyon. 9(5). e15839–e15839. 5 indexed citations
11.
Rao, Ting, Chen Wu, Tianbao Song, et al.. (2023). DUSP2 affects bladder cancer prognosis by down-regulating MEK/ERK and P38 MAPK signaling pathways through PTPN7. Cellular Signalling. 112. 110893–110893. 8 indexed citations
12.
Yang, Xin, Rui Chen, Yan Chen, et al.. (2022). Methyltransferase SETD2 inhibits tumor growth and metastasis via STAT1–IL‐8 signaling‐mediated epithelial–mesenchymal transition in lung adenocarcinoma. Cancer Science. 113(4). 1195–1207. 13 indexed citations
13.
Yang, Xin, Yan Chen, You Zhou, et al.. (2021). GPC5 suppresses lung cancer progression and metastasis via intracellular CTDSP1/AhR/ARNT signaling axis and extracellular exosome secretion. Oncogene. 40(25). 4307–4323. 15 indexed citations
14.
W, Liu, et al.. (2020). A Review of Research Progress in Multidrug-Resistance Mechanisms in Gastric Cancer. SHILAP Revista de lepidopterología. 1 indexed citations
15.
Wei, Hongyan, Fang Fu, Zhu X, et al.. (2019). A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro. SHILAP Revista de lepidopterología. 8 indexed citations
16.
Wu, Chen, et al.. (2019). Insulin-like growth factor II mRNA-binding protein 3 promotes cell proliferation, migration and invasion in human glioblastoma. SHILAP Revista de lepidopterología. 1 indexed citations
17.
Ma, Siyu, Chen Wu, Bin Wang, et al.. (2019). Entry-Prohibited Effect of kHz Pulsed Magnetic Field Upon Interaction Between SPIO Nanoparticles and Mesenchymal Stem Cells. IEEE Transactions on Biomedical Engineering. 67(4). 1152–1158. 20 indexed citations
18.
Su, Fei, et al.. (2019). Survival benefit of higher fraction dose delivered by three-dimensional conformal radiotherapy in hepatocellular carcinoma smaller than 10 cm in size. SHILAP Revista de lepidopterología. 1 indexed citations
19.
Zhang, Yuqing, Lujun Chen, Xiao Zheng, et al.. (2018). The expression of human endogenous retrovirus subfamily H long terminal repeat associating protein 2 in lung cancer tissue and it’s clinical significance. Zhonghua shiyan waike zazhi. 35(11). 2142–2146. 1 indexed citations
20.
Wu, Chen. (2014). LC-MS/MS DETERMINATION OF ORAL BIOAVAILABILITY OF AKEBIA SAPONIN D IN RAT. Journal of Beijing Normal University. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoli Zhu Breakdown of academic impact, for papers by Dandan Fan Breakdown of academic impact, for papers by Wei Mu Breakdown of academic impact, for papers by Johannes Winkler Breakdown of academic impact, for papers by Chenguang Zhang Breakdown of academic impact, for papers by Xingwen Wang Breakdown of academic impact, for papers by Frances L. Byrne Breakdown of academic impact, for papers by Antonia Marazioti Breakdown of academic impact, for papers by Lin Zhong Breakdown of academic impact, for papers by Shuxia Zhang
Rankless by CCL
2026